# COMPASS Study for Metastatic Castration-resistant Prostate Cancer

> **NCT07050433** · — · RECRUITING · sponsor: **Duke University** · enrollment: 48 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** CXCR2 as a biomarker

## Key facts

- **NCT ID:** NCT07050433
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-07
- **Primary completion:** 2027-07-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07050433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07050433, "COMPASS Study for Metastatic Castration-resistant Prostate Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07050433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*